These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25440358)

  • 41. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment outcomes of tissue plasminogen activator infusion for branch atheromatous disease.
    Deguchi I; Hayashi T; Kato Y; Nagoya H; Ohe Y; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e168-72. PubMed ID: 23246192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intra-arterial therapy for acute ischemic stroke under general anesthesia versus monitored anesthesia care.
    John S; Thebo U; Gomes J; Saqqur M; Farag E; Xu J; Wisco D; Uchino K; Hussain MS
    Cerebrovasc Dis; 2014; 38(4):262-7. PubMed ID: 25401730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical outcomes after intravenous fibrinolysis in cryptogenic strokes with or without patent foramen ovale.
    Chang JJ; Chiem T; Alderazi YJ; Chapple K; Restrepo L
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e492-9. PubMed ID: 23871701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stroke Mimics: An Important Source of Bias in Acute Ischemic Stroke Research.
    Garg R; Rech MA; Schneck M
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2475-2480. PubMed ID: 31256984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
    Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
    N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center.
    Hemmen TM; Meyer BC; McClean TL; Lyden PD
    J Stroke Cerebrovasc Dis; 2008; 17(1):23-5. PubMed ID: 18190817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Retrospective Cohort Study on the Use of Intravenous Thrombolysis in Stroke Mimics.
    Sivakumaran P; Gill D; Mahir G; Baheerathan A; Kar A
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1057-1061. PubMed ID: 26856459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost burden of stroke mimics and transient ischemic attack after intravenous tissue plasminogen activator treatment.
    Goyal N; Male S; Al Wafai A; Bellamkonda S; Zand R
    J Stroke Cerebrovasc Dis; 2015 Apr; 24(4):828-33. PubMed ID: 25735708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia.
    Chernyshev OY; Martin-Schild S; Albright KC; Barreto A; Misra V; Acosta I; Grotta JC; Savitz SI
    Neurology; 2010 Apr; 74(17):1340-5. PubMed ID: 20335564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
    Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
    Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of increasing IV tPA-treated stroke mimic rates at CT-based centers on clinical outcomes.
    Burton TM; Luby M; Nadareishvili Z; Benson RT; Lynch JK; Latour LL; Hsia AW
    Neurology; 2017 Jul; 89(4):343-348. PubMed ID: 28659427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Migraine History: A Predictor of Negative Diffusion-Weighted Imaging in IV-tPA-Treated Stroke Mimics.
    Lima J; Mehta T; Datta N; Bakradze E; Staff I; Beland D; Nouh A
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104282. PubMed ID: 31401044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue plasminogen activator for acute ischemic stroke: calculation of dose based on estimated patient weight can increase the risk of cerebral bleeding.
    García-Pastor A; Díaz-Otero F; Funes-Molina C; Benito-Conde B; Grandes-Velasco S; Sobrino-García P; Vázquez-Alén P; Fernández-Bullido Y; Villanueva-Osorio JA; Gil-Núñez A
    J Thromb Thrombolysis; 2015 Oct; 40(3):347-52. PubMed ID: 25995103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disparities in the Use of Intravenous t-PA among Ischemic Stroke Patients: Population-based Recent Temporal Trends.
    Faysel MA; Singer J; Cummings C; Stefanov DG; Levine SR
    J Stroke Cerebrovasc Dis; 2019 May; 28(5):1243-1251. PubMed ID: 30745230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiating Childhood Stroke From Mimics in the Emergency Department.
    Mackay MT; Yock-Corrales A; Churilov L; Monagle P; Donnan GA; Babl FE
    Stroke; 2016 Oct; 47(10):2476-81. PubMed ID: 27601378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient refusal of thrombolytic therapy for suspected acute ischemic stroke.
    Vahidy FS; Rahbar MH; Lal AP; Grotta JC; Savitz SI
    Int J Stroke; 2015 Aug; 10(6):882-6. PubMed ID: 23227830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system.
    Zweifler RM; Brody ML; Graves GC; U TT; Drinkard R; Cunningham S; Rothrock JF
    Neurology; 1998 Feb; 50(2):501-3. PubMed ID: 9484380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.